10X Fund Issues Statement on Exercise of Additional 200,000 Galectin Therapeutics Warrants
November 04, 2013 08:58 ET
|
10X Fund
NICEVILLE, Fla., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Rod D. Martin, Co-Founder and Managing Member of 10X Capital Management, LLC, whose 10X Fund is the largest shareholder in Galectin Therapeutics...
10X Fund Issues Statement on Sale of Shares, Bullish Outlook Regarding Galectin Therapeutics
October 17, 2013 08:05 ET
|
10X Fund
NICEVILLE, Fla., Oct. 17, 2013 (GLOBE NEWSWIRE) -- Rod D. Martin, Co-Founder and Managing Member of 10X Capital Management, LLC, whose 10X Fund is the largest shareholder in Galectin Therapeutics...